Clinical trial
Safety and Immunogenicity of Oral Cholera Vaccine in Kolkata
NCT00119197 · International Vaccine Institute, Other · Completed
Key facts
| NCT number | NCT00119197 |
|---|---|
| Title | Safety and Immunogenicity of Oral Cholera Vaccine in Kolkata |
| Official title | Safety and Immunogenicity of a Killed, Oral Cholera Vaccine in Indian Subjects in Eastern Kolkata, West Bengal |
| Lead sponsor | International Vaccine Institute, Other |
| Collaborators | National Institute of Cholera and Enteric Diseases, India Indian Council of Medical Research Shantha Biotechnics Limited Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cholera |
| Intervention type | Biological |
| Interventions | killed whole cell oral cholera vaccine, Heat Killed E. coli |
| Enrollment | 200 |
| Start date | Aug 1, 2005 |
| Primary completion | Jun 1, 2006 |
| Completion | Jul 1, 2006 |
| First posted | Jul 13, 2005 |
| Last update posted | Jul 4, 2008 |
| Countries | India |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: